Skip to main content

Advertisement

Log in

Clinicopathological studies on the use of laser-activated adipose-derived stromal vascular fraction in treatment of streptozotocin-induced diabetes in rats

  • Original Article
  • Published:
Comparative Clinical Pathology Aims and scope Submit manuscript

Abstract

Diabetes mellitus (DM) is associated with severe progressive degenerative complications in many organs especially diabetic nephropathy (DN). Adipose-derived stromal vascular fraction (SVF) is easily obtained and has abundant viable stem cell number obviating extensive expansion in culture; thus, SVF utilization provides promising anticipation. Low-intensity laser irradiation (LILI) was found to strengthen the therapeutic effect of non-expanded SVF through enhancing viability, protein expression, and migration of stem cells. The current study aimed to demonstrate the effect of transplanted laser-activated SVF in streptozotocin (STZ)-induced diabetic rats. Forty-five male Sprague Dawley rats were used in this experiment and divided randomly into four groups: (I) control group, (II) diabetic untreated group, (III) and (IV) diabetic-treated groups in which laser-activated SVF transplantation performed as a single and multiple IP injections, respectively, (V) cell tracking group. DM was induced by a single intraperitoneal (IP) injection of STZ at a dose of 55 mg/kg. Rats received single and multiple IP SVF injections, at a dose of 1.5 × 106 nucleated cells/rat on the 7th day of DM induction and a second dose injected in group IV on the 21th day of DM induction (2-week interval). Insulin gene expression quantification; glycemic profile evaluation (blood glucose, C-peptide, and glycosylated hemoglobin); biochemical, histopathological, and immunohistochemical parameters; and microalbuminuria were assessed in all experimental groups. Both SVF-treated groups exhibited improvement in glycemic profile which was confirmed by the significant increase of insulin gene expression and C-peptide levels. Liver transaminases, lipid profile, and microalbuminuria were normalized while serum creatinine and urea concentrations were ameliorated in treated groups compared to diabetic untreated rats. In conclusion, laser-activated SVF transplantation in diabetic rats triggered improvement of the diabetic state and ameliorated some of its complications with regard to the early interference. The second SVF treatment showed more improvement regarding the blood glucose, C-peptide, histopathology, and immunohistochemical results of the pancreas in diabetic states.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Abdallah AN, Shamaa AA, El-Tookhy OS, Abd El-Mottaleb EM (2016) Evaluation of low level laser-activated stromal vascular fraction as a single procedure for treatment of experimental chondral defects. Asian J Anim Sci 10:15–28

    CAS  Google Scholar 

  • Abdel Aziz MT, Ei-Asmar MF, Haidara M, Atta HM, Roshdy NK, Rashed LA, Sabry D, Youssef MA, Abdel Aziz AT, Moustafa M (2008) Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats. Med Sci Monit 14:249–255

    Google Scholar 

  • Abdel Aziz MT, Wassef MA, Ahmed HH, Rashed L, Mahfouz S, Aly MI, Hussein RE, Abdelaziz M (2014) The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy. Diabetol Metab Syndr 6:1–10

    Google Scholar 

  • Abdelrahim EA (2013) Histopathological change of the endocrine pancreas in male albino rat treated with the atypical antipsychotic clozapine. Romanian J Morphol Embryol 54:385–394

    CAS  Google Scholar 

  • Abrahamse H (2011) Inducing stem cell differentiation using low intensity laser irradiation: a possible novel therapeutic intervention. Cent Eur J Biol 6:695–698

    Google Scholar 

  • Al-Mahmood SM, Razak TA, Abdullah ST, Ahmad NN, Mohamed AH, Al-ani IM (2016) A comprehensive study of chronic diabetes complications in streptozotocin-induced diabetic rat. Makara J Heal Res 20:48–56

    Google Scholar 

  • Bancroft J, Gamble M (2008) Theory and practice of histological techniques, 6th edn. Churchill Livingstone, Elsevier, China

    Google Scholar 

  • Bell GI, Broughton HC, Levac KD, Allan DA, Xenocostas A, Hess DA (2012) Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev 21:97–109

    CAS  PubMed  Google Scholar 

  • Bhansali S, Kumar V, Saikia UN, Medhi B, Jha V (2015) Effect of mesenchymal stem cells transplantation on glycaemic profile and their localization in streptozotocin induced diabetic Wistar rats. Indian J Med Res142:63–71

    CAS  PubMed  Google Scholar 

  • Caplan AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341–347

    CAS  PubMed  Google Scholar 

  • Cardinali A, Nason G (2013) Costationarity of locally stationary time series using costat. J Stat Softw 55:1–22

    Google Scholar 

  • Chen YF, Shibu MA, Fan MJ, Chen MC, Viswanadha VP, Lin YL et al (2016) Purple rice anthocyanin extract protects cardiac function in STZ-induced diabetes rat hearts by inhibiting cardiac hypertrophy and fibrosis. J Nutr Biochem 3:98–105

    Google Scholar 

  • Davey GC, Patil SB, O’Loughlin A, O’Brien T (2014) Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus. Front Endocrinol 5:1–16

    Google Scholar 

  • Dombrowski F, Klotz L, Bannasch P, Evert M (2007) Renal carcinogenesis in models of diabetes in rats - metabolic changes are closely related to neoplastic development. Diabetologia 50:2580–2590

    CAS  PubMed  Google Scholar 

  • Eissa CS, Abd-elhady Z, Fargali LM, Hosny S (2018) Effect of losartan on islets of langerhans β-cells streptozotocin-induced diabetes in adult male albino rats. Pharmacologia 1–12

  • El Barky AR, Ezz AA, Alm-Eldeen AA, Hussein SA, Hafez YA, Mohamed TM (2018) Can stem cells ameliorate the pancreatic damage induced by streptozotocin in rats? Can J Diabetes 42:61–70

    PubMed  Google Scholar 

  • El-domouky AM, Hegab AS, Al-shahat A, Raafat N (2017) Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus. Int J Biochem Cell Biol 87:77–85

    Google Scholar 

  • Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yañez AJ, Conget PA (2008) Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 14:631–640

    CAS  PubMed  Google Scholar 

  • Fang Y, Tian X, Bai S, Fan J, Hou W, Tong H, Li D (2012) Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway. Int J Mol Med 30:85–92

    CAS  PubMed  Google Scholar 

  • Frazier KS, Seely JC, Hard GC, Betton G, Burnett R, Nakatsuji S, Nishikawa A, Durchfeld-Meyer B, Bube A (2012) Proliferative and nonproliferative lesions of the rat and mouse urinary system. Tox Path 40:14–86

    Google Scholar 

  • Gabr MM, Sobh MM, Zakaria MM, Refaie AF, Ghoneim MA (2008) Transplantation of insulin-producing clusters derived from adult bone marrow stem cells to treat diabetes in rats. Exp Clin Transplant 6:236–243

    PubMed  Google Scholar 

  • Gabr MM, Zakaria MM, Refaie AF, Ismail AM, Khater SM, Ashamallah SA, Azzam MM, Ghoneim MA (2013) Insulin-producing cells from adult human bone marrow mesenchymal stromal cells could control streptozotocin- induced diabetes in nude mice. Cell Transplant 22:133–145

    PubMed  Google Scholar 

  • Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, Agrawal YO (2016) Challenges and issues with streptozotocin-induced diabetes: a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chem Biol Interact 244:49–63

    CAS  PubMed  Google Scholar 

  • Hamza AH, Al-bishri WM, Damiati LA, Ahmed HH (2017) Mesenchymal stem cells :a future experimental exploration for recession of diabetic nephropathy. Ren Fail 3:67–76

    Google Scholar 

  • Houlihan DD, Newsome PN (2008) Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroentrology 135:438–450

    CAS  Google Scholar 

  • Hu J, Fu Z, Chen Y, Tang N, Wang L, Wang F, Sun R, Yan S (2015) Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats. Endocr J 62:339–352

    CAS  PubMed  Google Scholar 

  • Hu J, Wang Y, Gong H, Yu C, Guo C, Wang F, Yan S, Xu H (2016) Long term effect and safety of Wharton’s jelly-derived mesenchymal stem cells on type 2 diabetes. Exp Ther Med 12:1857–1866

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ishimura D, Yamamoto N, Tajima K, Ohno A, Yamamoto Y, Washimi O, Yamada H (2008) Differentiation of adipose-derived stromal vascular fraction culture cells into chondrocytes using the method of cell sorting with a mesenchymal stem cell marker. Tohoku J Exp Med 216:149–156

    PubMed  Google Scholar 

  • Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang X, Shao Y, Yang S, Han ZC (2011) Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med China 5:94–100

    Google Scholar 

  • Kang H, Yang C, Ahn H, Kang E, Hong E, Jeung (2014) Effects of xenoestrogens on streptozotocin-induced diabetic mice. J Physiol Pharmacol 65:273–282

    CAS  PubMed  Google Scholar 

  • Li P, Zhang R, Sun H, Chen L, Liu F, Yao C, Du M, Jiang X (2013) PKH26 can transfer to host cells in vitro and vivo. Stem Cells Dev 22:340–344

    PubMed  Google Scholar 

  • Little MH, Kairath P (2016) Regenerative medicine in kidney disease. Kidney Int 90:289–299

    PubMed  Google Scholar 

  • Liu Z, Li J, Li P, Bai M, Guo Y, Han M, Zhang F, Ahmed R, Jin S (2016a) Stem cell transplantation for the treatment of liver diseases: a systematic review and meta-analysis. Turk J Gastroenterol 27:499–508

    PubMed  Google Scholar 

  • Liu G-Y, Liu J, Wang Y, Liu Y, Shao Y, Han Y, Qin Y, Xiao F, Feili P, Zhao L, Gu E, Chen S, Gao L, Wu C, Hu X, Duan H (2016b) Adipose-derived mesenchymal stem cells ameliorate lipid metabolic disturbance in mice. Stem Cells Transl Med 5:1162–1170

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mousa F, Abdel-aziz KK, Abdel Gawad H, Mahmoud SS, Elgamel MS (2016) Bone marrow-derived mesenchymal stem cells infusion ameliorates hyperglycemia, dyslipidemia, liver and kidney functions in diabetic rats. Int J Sci Res 5:1624–1631

    Google Scholar 

  • Pourghasem M, Shafi H, Babazadeh Z (2015) Histological changes of kidney in diabetic nephropathy. Caspian J Int Med 6:120–127

    Google Scholar 

  • Ribback S, Cigliano A, Kroeger N, Pilo MG, Terracciano L, Burchardt M, Bannasch P, Calvisi DF, Dombrowski F (2015) PI3K / AKT / mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men. Oncotarget 6:13036–13048

    PubMed  PubMed Central  Google Scholar 

  • Riordan NH, Ichim TE, Min W, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B (2009) Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. J Transl Med 7:29–37

    PubMed  PubMed Central  Google Scholar 

  • Rookmaaker MB, Verhaar MC, de Boer HC, Goldschmeding R, Joles JA, Koomans HA, Grone H, Rabelink TJ (2007) Met-RANTES reduces endothelial progenitor cell homing to activated ( glomerular ) endothelium in vitro and in vivo. Am J Physiol Renal Physiol 293:624–630

    Google Scholar 

  • Shibuya M (2013) Endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 153:13–19

    CAS  PubMed  Google Scholar 

  • Thadani JM, Marathe A, Vakodikar S, Kshatriya P, Modi D, Vyas R, Vyas B (2017) Treatment of type I diabetes using autologous adipose derived mesenchymal stem cells translated to insulin secreting islet like cell aggregates. J Case Reports 7:235–238

    Google Scholar 

  • Wang S, Li Y, Zhao J, Zhang J, Huang Y (2013) Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Biol Blood Marrow Transplant 19:538–546

    PubMed  Google Scholar 

  • Wang H, Qiu X, Ni P, Qiu X, Lin X, Wu W, Xie L, Lin L, Min J, Lai X, Chen Y, Ho G, Ma L (2014) Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats. Int J Mol Med 33:263–270

    PubMed  Google Scholar 

  • Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue multilineage cells from human adipose tissue. Tissue Eng 7:211–228

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ghada M. Khalil.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sayed, S.Y., Salem, S.I., Abdallah, A.N. et al. Clinicopathological studies on the use of laser-activated adipose-derived stromal vascular fraction in treatment of streptozotocin-induced diabetes in rats. Comp Clin Pathol 28, 1515–1526 (2019). https://doi.org/10.1007/s00580-019-03008-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00580-019-03008-8

Keywords

Navigation